Guggenheim Capital’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,960
| Closed | -$75.5K | – | 1675 |
|
|
2024
Q4 | $75.5K | Sell |
10,960
-1,411
| -11% | -$9.7K | ﹤0.01% | 1666 |
|
|
2024
Q3 | $91.2K | Sell |
12,371
-4,188
| -25% | -$39.1K | ﹤0.01% | 1835 |
|
|
2024
Q2 | $175K | Buy |
16,559
+630
| +4% | +$7.98K | ﹤0.01% | 1783 |
|
|
2024
Q1 | $220K | Buy |
15,929
+108
| +0.7% | +$1.69K | ﹤0.01% | 1764 |
|
|
2023
Q4 | $307K | Buy |
+15,821
| New | +$292K | ﹤0.01% | 1652 |
|
|
2023
Q1 | – | Sell |
-15,297
| Closed | -$645K | – | 1981 |
|
|
2022
Q4 | $645K | Sell |
15,297
-493
| -3% | -$19K | 0.01% | 1371 |
|
|
2022
Q3 | $527K | Sell |
15,790
-1,915
| -11% | -$79.7K | ﹤0.01% | 1460 |
|
|
2022
Q2 | $767K | Sell |
17,705
-1,966
| -10% | -$90.2K | 0.01% | 1355 |
|
|
2022
Q1 | $942K | Buy |
19,671
+1,077
| +6% | +$53.4K | 0.01% | 1390 |
|
|
2021
Q4 | $944K | Buy |
+18,594
| New | +$827K | ﹤0.01% | 1396 |
|
|
2021
Q3 | – | Sell |
-5,722
| Closed | -$324K | – | 2197 |
|
|
2021
Q2 | $324K | Sell |
5,722
-2,221
| -28% | -$126K | ﹤0.01% | 1993 |
|
|
2021
Q1 | $420K | Sell |
7,943
-51
| -0.6% | -$2.78K | ﹤0.01% | 1805 |
|
|
2020
Q4 | $437K | Sell |
7,994
-153
| -2% | -$8.05K | ﹤0.01% | 1687 |
|
|
2020
Q3 | $408K | Buy |
8,147
+157
| +2% | +$7.44K | ﹤0.01% | 1516 |
|
|
2020
Q2 | $305K | Buy |
+7,990
| New | +$257K | ﹤0.01% | 1605 |
|
|
2020
Q1 | – | Sell |
-5,842
| Closed | -$239K | – | 1952 |
|
|
2019
Q4 | $239K | Sell |
5,842
-438
| -7% | -$17.9K | ﹤0.01% | 1922 |
|
|
2019
Q3 | $267K | Sell |
6,280
-11,165
| -64% | -$468K | ﹤0.01% | 1896 |
|
|
2019
Q2 | $860K | Sell |
17,445
-750
| -4% | -$38.1K | 0.01% | 1416 |
|
|
2019
Q1 | $871K | Sell |
18,195
-17,283
| -49% | -$1.05M | 0.01% | 1451 |
|
|
2018
Q4 | $2.18M | Sell |
35,478
-19,891
| -36% | -$1.34M | 0.02% | 1003 |
|
|
2018
Q3 | $4.56M | Buy |
55,369
+20,294
| +58% | +$1.61M | 0.03% | 775 |
|
|
2018
Q2 | $2.74M | Sell |
35,075
-2,641
| -7% | -$205K | 0.02% | 1061 |
|
|
2018
Q1 | $2.78M | Sell |
37,716
-5,137
| -12% | -$365K | 0.01% | 1402 |
|
|
2017
Q4 | $2.92M | Sell |
42,853
-47,446
| -53% | -$3.07M | 0.01% | 1378 |
|
|
2017
Q3 | $5.55M | Sell |
90,299
-3,657
| -4% | -$224K | 0.01% | 1001 |
|
|
2017
Q2 | $5.9M | Sell |
93,956
-42,523
| -31% | -$2.42M | 0.02% | 932 |
|
|
2017
Q1 | $7.58M | Buy |
136,479
+61,786
| +83% | +$3.18M | 0.02% | 794 |
|
|
2016
Q4 | $3.57M | Buy |
74,693
+2,020
| +3% | +$113K | 0.01% | 1224 |
|
|
2016
Q3 | $4.71M | Sell |
72,673
-5,767
| -7% | -$324K | 0.01% | 1044 |
|
|
2016
Q2 | $3.62M | Sell |
78,440
-2,788
| -3% | -$112K | 0.01% | 1165 |
|
|
2016
Q1 | $3.11M | Buy |
81,228
+6,959
| +9% | +$230K | 0.01% | 1270 |
|
|
2015
Q4 | $2.81M | Sell |
74,269
-55,486
| -43% | -$2.04M | 0.01% | 1369 |
|
|
2015
Q3 | $5.36M | Buy |
129,755
+88,327
| +213% | +$3.79M | 0.02% | 999 |
|
|
2015
Q2 | $1.95M | Sell |
41,428
-1,801
| -4% | -$97.4K | ﹤0.01% | 1793 |
|
|
2015
Q1 | $2.6M | Sell |
43,229
-20,986
| -33% | -$1.07M | 0.01% | 1560 |
|
|
2014
Q4 | $2.81M | Buy |
64,215
+2,998
| +5% | +$132K | 0.01% | 1478 |
|
|
2014
Q3 | $2.76M | Buy |
61,217
+30,704
| +101% | +$1.63M | 0.01% | 1537 |
|
|
2014
Q2 | $2.26M | Buy |
30,513
+6,248
| +26% | +$492K | 0.01% | 1704 |
|
|
2014
Q1 | $2.01M | Buy |
24,265
+2,549
| +12% | +$224K | 0.01% | 1799 |
|
|
2013
Q4 | $3M | Sell |
21,716
-7,990
| -27% | -$941K | 0.01% | 1427 |
|
|
2013
Q3 | $2.84M | Sell |
29,706
-11,267
| -27% | -$956K | 0.01% | 1385 |
|
|
2013
Q2 | $2.5M | Buy |
+40,973
| New | +$2.27M | 0.01% | 1388 |
|
Other funds holding NUS
PGCM
Guggenheim Capital's NUS Position: Q1 2025 in Review
Guggenheim Capital sold out of Nu Skin (NUS) in Q1 2025, closing a stake of 10,960 shares — an estimated $75.5K sold.
Guggenheim Capital first reported a position in NUS in Q2 2013 and held it in 42 quarters. The position peaked at $7.58M in Q1 2017. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.
- Guggenheim Capital reported no remaining Nu Skin position as of Q1 2025 after selling out during the quarter.
- Guggenheim Capital sold 10,960 Nu Skin shares in Q1 2025, an estimated $75.5K.
- Guggenheim Capital first reported a position in Nu Skin in Q2 2013 and held it in 42 quarters.
- Guggenheim Capital's Nu Skin position peaked at $7.58M in Q1 2017.
- 195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.
Based on Guggenheim Capital's 13F filing for Q1 2025, filed 14 May 2025.